Table 5.
Participant Responses to Survey Questions About Practice Characteristics
| Practice characteristic | Median (IQR) or No. (%) |
p-Value | ||
|---|---|---|---|---|
| Total (N=45) | California (n=20) | Non-California (n=25) | ||
| Percentage of practice involving cannabis recommendationsa | 76 (24–99) | 93 (20–100) | 57 (25–97) | 0.72 |
| No. of patients provided cannabis recommendationsb | 1200 (100–5000) | 2500 (150–8000) | 700 (100–3000) | 0.36 |
| Current practices | ||||
| Specific dosing recommendations | 28 (62) | 12 (60) | 16 (64) | >0.99 |
| Specific chemotype recommendations | 14 (31) | 9 (45) | 5 (20) | 0.11 |
| Specific phytoconstituent profile or ratio recommendations | 19 (42) | 7 (35) | 12 (48) | 0.54 |
| Specific delivery method recommendations | 26 (58) | 10 (50) | 16 (64) | 0.38 |
| Condition-specific treatment | 31 (69) | 13 (65) | 18 (72) | 0.75 |
| Other | 4 (9) | 2 (10) | 2 (8) | >0.99 |
| Received referrals from mainstream medical providersc | 30 (81) | 12 (71) | 18 (90) | 0.21 |
a
N=37, n=17 for California, and n=20 for non-California.
b
N=35, n=16 for California, and n=19 for non-California.
c
N=37, n=17 for California, and n=20 for non-California.
IQR, interquartile range.